Randomized phase III trial of surgery followed by mFOLFOX6 as adjuvant chemotherapy versus peri-operative mFOLFOX6 plus cetuximab for KRAS wild type resectable liver metastases of colorectal cancer

Trial Profile

Randomized phase III trial of surgery followed by mFOLFOX6 as adjuvant chemotherapy versus peri-operative mFOLFOX6 plus cetuximab for KRAS wild type resectable liver metastases of colorectal cancer

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 14 Dec 2016

At a glance

  • Drugs Cetuximab (Primary) ; Fluorouracil; Levofolinic acid; Oxaliplatin
  • Indications Colorectal cancer; Liver metastases
  • Focus Therapeutic Use
  • Acronyms EXPERT
  • Most Recent Events

    • 09 Dec 2016 Status changed from recruiting to active, no longer recruiting.
    • 23 May 2016 Results of a pooled analysis from EXPERT and EXPERT-C trials (n=269) published in the Annals of Oncology
    • 01 May 2012 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top